<DOC>
	<DOCNO>NCT01668797</DOCNO>
	<brief_summary>The purpose study evaluate efficacy brexpiprazole compare placebo maintenance treatment adult schizophrenia .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability Brexpiprazole ( OPC-34712 ) Maintenance Treatment Adults With Schizophrenia</brief_title>
	<detailed_description>Schizophrenia severely debilitate mental illness affect approximately 1 % world population . Hallucinations delusion strike characteristic positive symptom schizophrenia ; however , subtle negative symptom ( eg , social withdrawal lack emotion , energy , motivation ) may also present . The first antipsychotic develop treatment schizophrenia effective positive symptom , show little efficacy negative symptom also associate high incidence side effect . Second generation antipsychotic , represent significant advancement treatment psychotic disorder effective time exhibit few side effect first generation antipsychotic . Although generally safer first generation antipsychotic , second-generation antipsychotic devoid undesirable side effect Hyperprolactinemia weight gain . In addition , safety drug vary considerably .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Patients age 18 year old less 65 year , inclusive ( time inform consent ) Subjects current diagnosis schizophrenia , define DSMIVTR criterion history illness least three year prior screen ( per subject , family , healthcare provider , previous medical record ) . Subjects stable living environment , demonstrate ability provide contact information and/or family/friend ( ) /caregiver ( ) . Subjects show previous response antipsychotic treatment past year . Subjects currently treat oral depot antipsychotic clozapine recent lapse antipsychotic treatment require chronic treatment antipsychotic medication stabilization . Subjects experience current acute exacerbation psychotic symptom require stabilization Subjects history relapse and/or exacerbation symptom receive antipsychotic treatment . Female patient breastfeed positive pregnancy test ( urine ) result prior receive investigational medicinal product Patients present first episode schizophrenia base clinical judgment investigator Patients diagnose disease schizophrenia ( schizoaffective disorder , major depressive disorder , bipolar disorder , posttraumatic stress disorder , anxiety disorder , delirium , dementia , amnesia , cognitive disorder ) base current DSMIVTR Axis Î™ criterion , diagnose personality disorder ( borderline , paranoid , histrionic , schizotypal , schizoid , antisocial ) Subjects experience acute depressive symptom within past 30 day Subjects schizophrenia consider resistant/refractory antipsychotic treatment history Subjects significant risk violent behavior ; represent risk commit suicide Subjects clinically significant tardive dyskinesia Subjects currently treat insulin diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>